Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid Tumors
Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid Tumors
description
clinical trial
@en
name
Study Evaluating the Safety, P ...... s With Metastatic Solid Tumors
@en
type
label
Study Evaluating the Safety, P ...... s With Metastatic Solid Tumors
@en
prefLabel
Study Evaluating the Safety, P ...... s With Metastatic Solid Tumors
@en
P17
P1476
An Open-Label, Multicenter, Do ...... s With Metastatic Solid Tumors
@en
P3098
NCT02665416
P580
2016-01-25T00:00:00Z
P582
2020-06-09T00:00:00Z